Shanghai issued a new notice on volume purchase, and the replacement of selected drugs and the replacement of non selected drugs began to accelerate
Time of Update: 2019-12-09
At the same time, it is pointed out that the city's designated retail pharmacies for medical insurance should refer to the priority purchase and sales volume purchase of selected drugs by medical institutions.
The national lowest price is not real 23 drugs are complained
Time of Update: 2019-10-27
On November 14, 2018, Zhejiang Pharmaceutical purchase platform issued the notice on filling in and linkage of the national minimum online transaction price of online trading products in Zhejiang Province in 2018.
The traditional Chinese medicine pharmaceutical and equipment industry should not forget the technological transformation while pursuing the drama "the strategy of prolonging the new year
Time of Update: 2018-08-17
Strengthening the training of talents and promoting the development of intelligent manufacturing of traditional Chinese medicine will be an effective way to improve the quality of traditional Chinese medicine.
How about consistency assessment? Respect the clinical choice of medical institutions
Time of Update: 2018-04-28
Source: Cypress blue 2018-4-28 Medical Network April 28 news pharmaceutical enterprises that have passed the consistency evaluation, your basin of cold water is here, please accept
Change of hepatitis C drug market: three new foreign drugs pass the technical review
Time of Update: 2017-03-22
The food and Drug Administration told Caixin that the DAA combined program can increase the virus response rate of the relatively difficult to cure genotype 1 hepatitis C patients from 40% to more than 90%.
[MAH] Chinese original medicine bid farewell to the era of selling young crops
Time of Update: 2017-01-16
On January 12, the State Food and Drug Administration (CFDA) issued a notice approving the listing of domestic generic drugs, such as gefitinib tablets produced by Qilu
First line clinicians worry that generic drugs are still difficult to compete with the original drugs
Time of Update: 2016-12-08
Source: e-medicine Facebook 2016-12-08 based on the current situation of generic drugs in China, the original drug is still the best choice for the clinical front line.
A case study on the substitution of domestic imatinib for imported imatinib
Time of Update: 2016-08-02
In 2013, imatinib mesylate, the first domestic product, was approved for marketing by CFDA, and obtained the first new drug imitation certificate, breaking the price monopoly situation of foreign enterprises.
Baiyunshan and huangtuyiyuan increase the research and development of traditional Chinese Medicine
Time of Update: 2015-05-20
On May 5, the national development and Reform Commission, together with the national health and Family Planning Commission, the Ministry of human resources and social security
The price of Salvia miltiorrhiza is difficult to rise
Time of Update: 2012-08-30
The planting area of Salvia miltiorrhiza in Juxian County, Shandong Province has increased by about 40% over the same period last year.